More specifically, the risk allele rs11672691-G enhances the binding activity of the novel transcription factor HOXA2, which in turn regulates expression of PCAT19 in prostate cancer through enhancer–promoter loop formation (Figure 2B) [135]. This evidence concerns the gene HOXA2 and prostate cancer.